DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
51 hedge funds and large institutions have $12.7M invested in DMK Pharmaceuticals Corporation Common Stock in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
36% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 14
Holders
51
Holding in Top 10
–
Calls
$718K
Puts
$696K
Top Buyers
| 1 | +$2.24M | |
| 2 | +$364K | |
| 3 | +$203K | |
| 4 |
VF
Virtu Financial
New York
|
+$77K |
| 5 |
BlackRock
New York
|
+$66.8K |
Top Sellers
| 1 | -$824K | |
| 2 | -$160K | |
| 3 | -$151K | |
| 4 |
Goldman Sachs
New York
|
-$124K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$117K |